Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

6.820 -0.070 (-1.02%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,709
Open 6.750
Bid (Size) 6.800 (5)
Ask (Size) 6.880 (1)
Prev. Close 6.890
Today's Range 6.750 - 6.878
52wk Range 3.750 - 11.99
Shares Outstanding 13,415,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss
Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform. 
Via Chartmill

Performance

YTD
-16.8%
-16.8%
1 Month
+8.3%
+8.3%
3 Month
+8.3%
+8.3%
6 Month
-6.7%
-6.7%
1 Year
+71.4%
+71.4%

More News

Read More
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
Earnings Scheduled For September 15, 2025
Via Benzinga
Insights Ahead: Champions Oncology's Quarterly Earnings
Via Benzinga
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
Via ACCESS Newswire
Champions Oncology Reports Record Annual Revenue of $57 Million
Via ACCESS Newswire
Earnings Scheduled For July 23, 2025
Via Benzinga
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
Via Benzinga
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
Via ACCESS Newswire
Champions Oncology Announces Appointment of New CEO
Via ACCESS Newswire
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
Via ACCESS Newswire
Recap: Champions Oncology Q2 Earnings
Via Benzinga
A Peek at Champions Oncology's Future Earnings
Via Benzinga
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
Via ACCESS Newswire
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
Via ACCESS Newswire
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
Via ACCESS Newswire
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
Via ACCESS Newswire
Earnings Scheduled For March 11, 2025
Via Benzinga
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
Via ACCESS Newswire
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
Via ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
Via ACCESSWIRE
Earnings Scheduled For December 11, 2024
Via Benzinga

Frequently Asked Questions

Is Champions Oncology, Inc. - Common Stock publicly traded?
Yes, Champions Oncology, Inc. - Common Stock is publicly traded.
What exchange does Champions Oncology, Inc. - Common Stock trade on?
Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Champions Oncology, Inc. - Common Stock?
The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market
What is the current price of Champions Oncology, Inc. - Common Stock?
The current price of Champions Oncology, Inc. - Common Stock is 6.820
When was Champions Oncology, Inc. - Common Stock last traded?
The last trade of Champions Oncology, Inc. - Common Stock was at 10/27/25 03:59 PM ET
What is the market capitalization of Champions Oncology, Inc. - Common Stock?
The market capitalization of Champions Oncology, Inc. - Common Stock is 91.49M
How many shares of Champions Oncology, Inc. - Common Stock are outstanding?
Champions Oncology, Inc. - Common Stock has 91M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.